Utah Medical Products, Inc. (UTMD)

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	39.27	40.9	50.22	52.28	49.05	42.18
Revenue Growth (YoY)	-19.92%	-18.56%	-3.94%	6.58%	16.30%	-10.08%
Cost of Revenue	16.36	16.76	20.19	20.09	18.14	16.63
Gross Profit	22.92	24.14	30.04	32.2	30.92	25.55
Selling, General & Admin	7.65	7.6	11.04	11.91	11.51	11.35
Research & Development	0.7	0.81	0.56	0.49	0.53	0.49
Operating Expenses	8.35	8.41	11.6	12.41	12.04	11.84
Operating Income	14.57	15.73	18.44	19.79	18.88	13.71
Interest & Investment Income	3.37	3.37	3.04	0.66	0.17	0.11
Currency Exchange Gain (Loss)	0	0	-0.01	-	-	-
Other Non Operating Income (Expenses)	-0.37	-0.16	0.28	0.21	0.02	0.02
EBT Excluding Unusual Items	17.57	18.94	21.75	20.66	19.06	13.84
Legal Settlements	-1.7	-2.14	-1.66	-	-	-
Pretax Income	15.86	16.8	20.09	20.66	19.06	13.84
Income Tax Expense	2.9	2.93	3.45	4.19	4.27	3.04
Net Income	12.96	13.87	16.64	16.47	14.79	10.8
Net Income to Common	12.96	13.87	16.64	16.47	14.79	10.8
Net Income Growth	-20.87%	-16.60%	0.98%	11.39%	36.95%	-26.68%
Shares Outstanding (Basic)	3	4	4	4	4	4
Shares Outstanding (Diluted)	3	4	4	4	4	4
Shares Change (YoY)	-5.68%	-3.68%	-0.16%	-0.46%	-0.33%	-1.79%
EPS (Basic)	3.78	3.96	4.58	4.53	4.05	2.95
EPS (Diluted)	3.78	3.96	4.57	4.52	4.04	2.94
EPS Growth	-16.02%	-13.42%	1.20%	11.88%	37.41%	-25.36%
Free Cash Flow	-	14.6	21.64	20.34	20.65	19.28
Free Cash Flow Per Share	-	4.17	5.95	5.58	5.64	5.25
Dividend Per Share	1.210	1.205	1.185	1.165	0.855	1.120
Dividend Growth	1.68%	1.69%	1.72%	36.26%	-23.66%	1.82%
Gross Margin	58.35%	59.03%	59.81%	61.58%	63.03%	60.57%
Operating Margin	37.09%	38.46%	36.71%	37.85%	38.49%	32.50%
Profit Margin	33.00%	33.92%	33.12%	31.51%	30.15%	25.60%
Free Cash Flow Margin	-	35.70%	43.09%	38.90%	42.10%	45.70%
EBITDA	17.39	18.53	24.75	26.82	26.16	20.88
EBITDA Margin	44.28%	45.30%	49.28%	51.30%	53.33%	49.50%
D&A For EBITDA	2.82	2.8	6.32	7.03	7.28	7.17
EBIT	14.57	15.73	18.44	19.79	18.88	13.71
EBIT Margin	37.09%	38.46%	36.71%	37.85%	38.49%	32.50%
Effective Tax Rate	18.31%	17.43%	17.19%	20.26%	22.42%	21.98%

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q